52
Participants
Start Date
September 19, 2023
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
SPH4336 Tablets
SPH4336 Tablets ：Administered by oral; Letrozole tablets：Administered by oral; Fulvestrant injection：Administered by intravenous infusion; Exemestane：Administered by oral.
RECRUITING
Peking Union Medical College Hospital, Beijing
RECRUITING
Jilin Cancer Hospital, Changchun
RECRUITING
The first hospital of Jilin University, Changchun
RECRUITING
Harbin Medical University cancer Hospital, Harbin
RECRUITING
Jiangsu Province Hospital, Nanjing
RECRUITING
Anhui provincial hospital, Hefei
RECRUITING
The First Affiliated Hospital of Anhui Medical University, Hefei
RECRUITING
Zhejiang cancer Hospital, Hangzhou
RECRUITING
Chongqing University Three Gorges Hospital, Chongqing
RECRUITING
Xiangyang Central Hospital, Xiangyang
RECRUITING
The First Affiliated Hospital of Henan University of Science and Technology, Luoyang
RECRUITING
Anyang Cancer Hospital, Anyang
RECRUITING
Affiliated Cancer Hospital, Sun Yat-sen University, Guangzhou
RECRUITING
Liuzhou people's Hospital, Liuzhou
RECRUITING
The second people's hospital of neijiang, Neijiang
RECRUITING
General Hospital of Ningxia Medical University, Yinchuan
RECRUITING
Cancer Hospital of Xinjiang Medical University, Ürümqi
RECRUITING
The Fourth Hospital of Hebei Medical University, Shijiazhuang
RECRUITING
Beijing Cancer Hospital, Beijing
RECRUITING
The First Affiliated Hospital of Bengbu Medical College, Bengbu
RECRUITING
Guangxi Medical University Cancer Hospital & Guangxi Cancer Institute, Nanning
RECRUITING
Tianjin Medical University Cancer Institute & Hospital, Tianjin
RECRUITING
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
RECRUITING
Xi'An International Medical Cancer Hospital, Xi'an
RECRUITING
Henan Cancer Hospital, Zhengzhou
Shanghai Pharmaceuticals Holding Co., Ltd
INDUSTRY